Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop

Ebola virus remains a global threat to public health and biosecurity, yet we still know relatively little about its pathogenesis and the complications that arise following recovery. With nearly 20,000 survivors from the 2013–2016 West African outbreak, as well as over 1,000 survivors of the recent...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Logan Banadyga, Wenjun Zhu, Shweta Kailasan, Katie A. Howell, Krzysztof Franaszek, Shihua He, Vinayakumar Siragam, Keding Cheng, Feihu Yan, Estella Moffat, Wenguang Cao, Anders Leung, Carissa Embury-Hyatt, M. Javad Aman, Xiangguo Qiu
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/909040b19d774466a013d0a904fb9c04
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:909040b19d774466a013d0a904fb9c04
record_format dspace
spelling oai:doaj.org-article:909040b19d774466a013d0a904fb9c042021-11-03T18:15:38ZAtypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop2161-21292150-751110.1128/mBio.01438-20https://doaj.org/article/909040b19d774466a013d0a904fb9c042021-02-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01438-20https://doaj.org/toc/2161-2129https://doaj.org/toc/2150-7511 Ebola virus remains a global threat to public health and biosecurity, yet we still know relatively little about its pathogenesis and the complications that arise following recovery. With nearly 20,000 survivors from the 2013–2016 West African outbreak, as well as over 1,000 survivors of the recent outbreak in the DRC, we must consider the consequences of virus persistence and recrudescent disease, even if they are rare.Logan BanadygaWenjun ZhuShweta KailasanKatie A. HowellKrzysztof FranaszekShihua HeVinayakumar SiragamKeding ChengFeihu YanEstella MoffatWenguang CaoAnders LeungCarissa Embury-HyattM. Javad AmanXiangguo QiuAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 12, Iss 1 (2021)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Logan Banadyga
Wenjun Zhu
Shweta Kailasan
Katie A. Howell
Krzysztof Franaszek
Shihua He
Vinayakumar Siragam
Keding Cheng
Feihu Yan
Estella Moffat
Wenguang Cao
Anders Leung
Carissa Embury-Hyatt
M. Javad Aman
Xiangguo Qiu
Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop
description Ebola virus remains a global threat to public health and biosecurity, yet we still know relatively little about its pathogenesis and the complications that arise following recovery. With nearly 20,000 survivors from the 2013–2016 West African outbreak, as well as over 1,000 survivors of the recent outbreak in the DRC, we must consider the consequences of virus persistence and recrudescent disease, even if they are rare.
format article
author Logan Banadyga
Wenjun Zhu
Shweta Kailasan
Katie A. Howell
Krzysztof Franaszek
Shihua He
Vinayakumar Siragam
Keding Cheng
Feihu Yan
Estella Moffat
Wenguang Cao
Anders Leung
Carissa Embury-Hyatt
M. Javad Aman
Xiangguo Qiu
author_facet Logan Banadyga
Wenjun Zhu
Shweta Kailasan
Katie A. Howell
Krzysztof Franaszek
Shihua He
Vinayakumar Siragam
Keding Cheng
Feihu Yan
Estella Moffat
Wenguang Cao
Anders Leung
Carissa Embury-Hyatt
M. Javad Aman
Xiangguo Qiu
author_sort Logan Banadyga
title Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop
title_short Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop
title_full Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop
title_fullStr Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop
title_full_unstemmed Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop
title_sort atypical ebola virus disease in a nonhuman primate following monoclonal antibody treatment is associated with glycoprotein mutations within the fusion loop
publisher American Society for Microbiology
publishDate 2021
url https://doaj.org/article/909040b19d774466a013d0a904fb9c04
work_keys_str_mv AT loganbanadyga atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
AT wenjunzhu atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
AT shwetakailasan atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
AT katieahowell atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
AT krzysztoffranaszek atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
AT shihuahe atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
AT vinayakumarsiragam atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
AT kedingcheng atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
AT feihuyan atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
AT estellamoffat atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
AT wenguangcao atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
AT andersleung atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
AT carissaemburyhyatt atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
AT mjavadaman atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
AT xiangguoqiu atypicalebolavirusdiseaseinanonhumanprimatefollowingmonoclonalantibodytreatmentisassociatedwithglycoproteinmutationswithinthefusionloop
_version_ 1718445469306191872